UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by New World Advisors LLC

New World Advisors LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 35.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 441 shares of the healthcare conglomerate’s stock after selling 242 shares during the period. New World Advisors LLC’s holdings in UnitedHealth Group were worth $223,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $30,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the third quarter worth approximately $37,000. DecisionPoint Financial LLC grew its stake in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares during the period. Highline Wealth Partners LLC purchased a new stake in UnitedHealth Group during the third quarter worth approximately $55,000. Finally, Legacy Investment Solutions LLC purchased a new stake in UnitedHealth Group during the third quarter worth approximately $57,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on UNH. Stephens boosted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Oppenheimer upped their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH opened at $465.58 on Monday. The firm has a 50-day moving average price of $519.27 and a 200 day moving average price of $560.44. The firm has a market capitalization of $428.46 billion, a PE ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 EPS. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.